BRIM Biotechnology is selling for under 39.45 as of the 3rd of December 2024; that is 5.85% down since the beginning of the trading day. The stock's lowest day price was 38.85. BRIM Biotechnology has hardly any chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for BRIM Biotechnology are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of November 2024 and ending today, the 3rd of December 2024. Click here to learn more.
Although BRIM Biotechnology's alpha and beta are two of the key measurements used to evaluate BRIM Biotechnology's performance over the market, the standard measures of volatility play an important role as well.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BRIM Biotechnology stock to make a market-neutral strategy. Peer analysis of BRIM Biotechnology could also be used in its relative valuation, which is a method of valuing BRIM Biotechnology by comparing valuation metrics with similar companies.
When running BRIM Biotechnology's price analysis, check to measure BRIM Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BRIM Biotechnology is operating at the current time. Most of BRIM Biotechnology's value examination focuses on studying past and present price action to predict the probability of BRIM Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BRIM Biotechnology's price. Additionally, you may evaluate how the addition of BRIM Biotechnology to your portfolios can decrease your overall portfolio volatility.